-
Changing landscape of pharma market in Central Asia & Russia
Dr. Preet Pal S.B.
September 26, 2021
Russia and parts of Central Asia have made the most significant regulatory changes in their history in 2021. They have almost completed the steps needed to form a unified market like the EU.
-
2020 Zhejiang Export Commodity Online Fair “Russia – API session” is now launched!
PharmaSources.com
October 27, 2020
The portals for the “Russia - API session” is now launched to welcome the participation of both pharmaceutical suppliers located in Zhejiang Province of China, as well as Russian buyers online.
-
Russia launches Sputnik Light vaccine into wide circulation
expresspharma
June 28, 2021
Sputnik Light deploys just the first dose of Russia's flagship Sputnik V vaccine, which uses a first shot and booster separated by a gap of at least 21 days.
-
Brazil’s Anvisa rejects import of Russia’s Covid-19 vaccine
pharmaceutical-technology
April 28, 2021
The Brazilian National Health Surveillance Agency (Anvisa) has rejected the import of the Russian Covid-19 vaccine, Sputnik V, citing a lack of consistent and reliable data.
-
Manufacture of Indian vaccine in Russia cannot be ruled out: Russian Foreign Minister
expresspharma
April 08, 2021
The RDIF has signed contracts with several Indian contractors to manufacture the Sputnik V vaccine to the tune of 700-750 million doses.
-
Russian President experienced slight side effects from COVID-19 vaccine: Reports
expresspharma
March 29, 2021
Putin did not reveal which of three Russian vaccines he had taken, saying only the doctor who inoculated him knows that.
-
Brazil could approve Russian coronavirus vaccine in days, says pharmaceutical firm
expresspharma
March 25, 2021
The Brazilian pharmaceutical company that plans to produce Russia’s coronavirus vaccine Sputnik V said on Tuesday it expects to overcome regulatory obstacles in “two or three” days to obtain authorisation to make and sell the shot in Brazil.
-
US accuses Russia of Covid-19 vaccine disinformation campaign
pharmaceutical-technology
March 10, 2021
The US Government has accused the Russian intelligence services of carrying out a disinformation campaign aimed at undermining confidence in Western-produced Covid-19 vaccines, including Pfizer and BioNTech’s mRNA product.
-
Russia grants approval to third Covid-19 vaccine for domestic use
pharmaceutical-technology
February 23, 2021
Russia has granted approval to its third Covid-19 vaccine for domestic use, with large-scale clinical trials yet to begin.
-
Glenmark gets marketing approval for Ryaltris, single nasal spray in Russia
expresspharma
February 22, 2021
Glenmark Pharmaceuticals announced that its Swiss subsidiary, Glenmark Specialty, received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris Nasal Spray – a fixed-dose combination nasal spray.